Skip to main content

MJFF Publications

641 - 650 of 7616 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • RESTRICTED
    Title: Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force
    Journal Name: Value in Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jval.2022.12.006
    Citation Count: 6
  • RESTRICTED
    Title: Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities
    Journal Name: Alzheimer Disease & Associated Disorders
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/wad.0000000000000556
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci13040599
    Citation Count: 5
  • RESTRICTED
    Title: Workflows Community Summit 2022: A Roadmap Revolution
    Journal Name:
    Publisher:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.5281/zenodo.7750670
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-32480-0
    Citation Count: 3
  • RESTRICTED
    Title: Sex differences in associations between APOE ε2 and longitudinal cognitive decline
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.13036
    Citation Count: 3
  • RESTRICTED
    Title: Identification of a Putative α-synuclein Radioligand Using an in silico Similarity Search
    Journal Name: Molecular Imaging and Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11307-023-01814-9
    Best OA location URL:
    Citation Count: 2
  • RESTRICTED
    Title: Developing better digital health measures of Parkinson’s disease using free living data and a crowdsourced data analysis challenge
    Journal Name: PLOS Digital Health
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pdig.0000208
    Citation Count: 0
  • RESTRICTED
    Title: Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51753
    Citation Count: 7
  • RESTRICTED
    Title: Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation
    Journal Name: Aging Cell
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/acel.13814
    Citation Count: 7
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.